Don’t let the high cost of brand transplant induction immunosuppression disrupt your treatment. We help eligible patients access Thymoglobulin (anti-thymocyte globulin, rabbit) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Thymoglobulin PAP for transplant patients.
Eligibility, transplant coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Hospital pharmacy | ~$9,000/dose | Save substantially |
| Inpatient billing | ~$10,000/dose | Save substantially |
| Specialty Pharmacy | ~$6,500/dose | Save substantially |
| Hospital direct | ~$5,500/dose | Save substantially |
PAP-approved | $0 | Manufacturer PAP |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Typically inpatient administration. PAP for uninsured/underinsured.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Thymoglobulin:
Still $5,000–$10,000 per dose per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Thymoglobulin assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Thymoglobulin is purified polyclonal IgG from rabbits immunized against human thymocytes. Powerful T-cell depleting agent used for transplant induction immunosuppression and treatment of acute kidney rejection.
How Thymoglobulin Works:
Polyclonal antibodies against multiple T-cell surface antigens cause T-cell depletion through complement-mediated lysis, antibody-dependent cellular cytotoxicity, and apoptosis. Profound and prolonged T-cell depletion.
Used as induction immunosuppression at transplant — particularly in high-risk patients (high PRA, ABO incompatible, repeat transplant) or to delay calcineurin inhibitor initiation in patients with delayed graft function. Also used for acute rejection treatment. For aplastic anemia: induces immune-mediated remission.
Form and use:
Thymoglobulin given as IV infusion typically over 4–6 hours through central venous access. Standard dose 1.5 mg/kg/day for 4–7 days (induction or rejection). Premedication with corticosteroid, acetaminophen, antihistamine to reduce infusion reactions.
Generic availability:
No biosimilar. Other rATG products: Grafalon (different rabbit ATG). ATGAM (horse ATG) — alternative for aplastic anemia (typically first-line for aplastic anemia per AA-SAA guidelines). Basiliximab (Simulect) — alternative induction agent for low/moderate-risk kidney transplant.
Warnings:
Cytokine release syndrome (especially first dose — fever, chills, hypotension; managed with premedication and slow infusion), serum sickness (~7–14 days post-treatment), thrombocytopenia, leukopenia, infections (severe immunosuppression — bacterial, viral, fungal, PJP; prophylaxis essential), malignancies (post-transplant lymphoproliferative disorder, lymphoma), severe allergic reactions.
$5,000–$10,000/dose, course $25,000–$60,000+. Hospital billing typically includes.
Powerful T-cell depletion at time of transplant — reduces early rejection, may allow delayed calcineurin inhibitor initiation. Used in high-risk transplant scenarios.
Thymoglobulin (rabbit ATG) — more T-cell-specific, longer duration of action, preferred for transplant. ATGAM (horse ATG) — first-line for aplastic anemia per current guidelines. Cross-reactivity considerations
Simulect (basiliximab — anti-IL-2 receptor) is alternative induction agent. Less T-cell depleting but better safety profile. Used in lower-risk transplant. Two doses (day 0 and day 4) vs Thymoglobulin’s 4–7 day course.
Delayed immune complex reaction ~7–14 days after rATG. Fever, rash, arthralgia, lymphadenopathy. Treated with steroids and supportive care.
Critical — PJP, CMV, fungal prophylaxis typically given. CMV monitoring.
Basiliximab alternative for kidney transplant induction. ATGAM for aplastic anemia. Hospital charity, PAP.
If facing Thymoglobulin cost, PAP and hospital billing assistance help. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.